Asset Details
Do you wish to reserve the book?
Interpretation of mebrofenin and etifenin hepatobiliary scintigraphy before major liver resection
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Interpretation of mebrofenin and etifenin hepatobiliary scintigraphy before major liver resection
Do you wish to request the book?
Interpretation of mebrofenin and etifenin hepatobiliary scintigraphy before major liver resection
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Interpretation of mebrofenin and etifenin hepatobiliary scintigraphy before major liver resection
2024
Overview
While the grade C liver failure rate of 1/8 versus 3/12 did not reach statistical significance, the cohort is too small to detect differences and the data is insufficient for the made conclusion. [...]other studies have suggested a lower cut-off might be safe, yet it should be stated the predictive value of the scintigraphy is primarily the prediction of safe liver resection when liver function is above the cut-off [4, 5–6]. A structure-distribution-relationship approach leading to the development of Tc-99m mebrofenin: an improved cholescintigraphic agent. Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
